Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Oncology·MeSH: Squamous Cell Carcinoma of Head and Neck
Prevalence
14.0 / 100K
Incidence
6.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)?
There are 1 clinical trial targeting Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) tracked by BioSniper.
What is the prevalence of Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)?
The estimated prevalence of Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) is approximately 14.0 per 100,000 population.
Deep-dive into Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis